Jejunal somatostatinoma
disease diseaseOn this page
Also known as Delta cell tumor of jejunumDelta cell tumor of the jejunumDelta cell tumour of jejunumDelta cell tumour of the jejunumjejunal delta cell somatostatin producing tumourjejunal somatostatin producing tumorjejunal somatostatin producing tumourjejunal somatostatin-producing NETjejunal somatostatin-producing neuroendocrine tumorjejunal somatostatin-producing neuroendocrine tumourSomatosatinoma of jejunumSomatosatinoma of the jejunum
Summary
Jejunal somatostatinoma (MONDO:0002563) is a disease. A subtype of jejunal neuroendocrine tumor, well differentiated, low or intermediate grade — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | jejunal somatostatinoma |
| Mondo ID | MONDO:0002563 |
| DOID | DOID:3216 |
| NCIT | C5787 |
| UMLS | C1334297 |
| MedGen | 233585 |
| GARD | 0023169 |
| Is cancer (heuristic) | no |
Also known as: Delta cell tumor of jejunum · Delta cell tumor of the jejunum · Delta cell tumour of jejunum · Delta cell tumour of the jejunum · jejunal delta cell somatostatin producing tumour · jejunal somatostatin producing tumor · jejunal somatostatin producing tumour · jejunal somatostatin-producing NET · jejunal somatostatin-producing neuroendocrine tumor · jejunal somatostatin-producing neuroendocrine tumour · Somatosatinoma of jejunum · Somatosatinoma of the jejunum
Disease family
Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › intestinal neoplasm › small intestine neoplasm › jejunal neoplasm › jejunal neuroendocrine tumor, well differentiated, low or intermediate grade › jejunal somatostatinoma
Related subtypes (1): jejunal neuroendocrine tumor G1
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.